GrantsResearch contracts funded by the ’Investissements d’avenir’, the European Community, the National Research Agency (ANR), and contracts in partnership with industry supplement the budget of the IBS. The most important grants obtained over the past five years are listed below : |
Grants obtained in 2021List under construction ANR grants obtained in 2021 : ANR générique " PRCI (Projet de recherche collaborative – international)
ANR générique 2021 - CE06 - Polymères, composites, physique et chimie de la matière molle, procédés - PRC
ANR générique - CE15 - Immunologie, Infectiologie et Inflammation - PRC
ANR générique - CE11 - Caractérisation des structures et relations structure-fonctions des macromolécules biologiques - PRC
ANR générique - CE12 - Génétique, génomique et ARN - PRC
ANR générique - CE14 - Physiologie et physiopathologie - PRC
ANR générique - CE16 - Neurosciences moléculaires et cellulaires - Neurobiologie du développement - PRC
ANR générique - CE18 - Innovation biomédicale - PRC
ANR générique - CE20 - Biologie des animaux, des organismes photosynthétiques et des microorganismes - PRC
ANR générique - CE29 - Chimie : analyse, théorie, modélisation
3rd French Investment Program ’EquipEx+’
Ligue contre le Cancer : Joanna Timmins (IBS/I2SR) has obtained funding from the Ligue Contre le Cancer for a project "Inhibition of the hNTH1- YB1 complex" which aims to characterize inhibitors of the interface between two human proteins : hNTH1 a DNA repair enzyme, and YB1, a transcription factor. This interface constitutes a therapeutic target for the treatment of tumors that have developed resistance to cisplatin. INCA projects « Biology & Cancer » : project "Complement and renal cancer : pathogenic factor and prognostic impact" - contact IBS : C. Gaboriaud (équipe CIRDis du groupe (CAID) |
Grants obtained in 2020ANR grants obtained in 2020 : ANR générique PRC-CE11 « Caractérisation des structures et relation structure-fonction des macromolécules biologiques »
ANR générique PRC-CE07 « Chimie moléculaire », project Glyco_SWIM (Glycosynthase-mediated synthesis of bacterial cell wall mimics), contact : A. Zapun (IBS/PG) ANR générique PRC-CE44 « Biochimie du vivant », project SAM4RIPP (Enzymes à radical SAM pour la biosynthèse de nouveaux RiPPsn), contact : Y. Nicolet (IBS/METALLO), ANR Flash-Covid-19
ANR Recherche-Action Covid-19
French Investment Program FRISBI was awarded four more years of funding dedicated to structural biology on 5 partner sites (Strasbourg, Grenoble, Marseille, Montpellier and Paris-Sud). This project will ultimately advance our understanding of how proteins, macromolecular complexes, and pathogenic agents such as viruses and bacteria interact with their cellular environment. Period : 2020-2024, contact IBS : C. Breyton et D. Hart H2020-MSCA-ITN-2020 grant : Research program GLYTUNES (A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis) - Period : march 2021 to february 2025 - Contact IBS : I. Gutsche (IBS/groupe MICA) ATIP-Avenir : Rebekka Wild (groupe SAGAG) is the winner of the ATIP-Avenir programme to develop a research project on the biosynthesis mechanisms of heparan sulphates. Ligue Contre le Cancer : Pauline Macheboeuf (IBS/PATBAC) has obtained funding from the Ligue Contre le Cancer for a project which aims to understand the structure & function of proteins that synthesize colibactin - Period : 2020-2021 (18 months), FINOVI : Malene Ringkjobing Jensen (IBS/FDP) has obtained funding from the Foundation Innovations in Infectiology (FINOVI) for a project that aims to study the structure, assembly and dynamics of the CPSF (Cleavage and polyadenylation specificity factor) complex of cryptosporidium parasites. The project is coordinated by Andrés Palencia (IAB, Grenoble) - Period : 24 months, iNEXT-DISCOVERY : IBS is a partner in a European infrastructure project (I3), which gives access to state-of-the-art structural biology instruments (NMR, cryo-EM, X-ray) to the European biology community. This contract funds a research project in NMR development, as well as mission fees for external European users of the NMR platform and machine usage fees. IBS contact : B. Brutscher - Period : 2020-2024. |
Grants obtained in 2019- ERC Advanced grant for Martin Blackledge (FDP group) : project DynamicAssemblies (Conformational studies of highly dynamic viral replication complexes), period 2019-2024 - ERC Starting grant for Sigrid Milles (FDP group) : project MultiMotif (Motif repeats in intrinsically disordered regions of the clathrin mediated endocytosis pathway), period 2019-2024 - ITN grants obtained in 2019 :
- Subvention Région Auvergne-Rhône-Alpes, Pack Ambition Recherche 2019 - projet Dyna4drugs, contact : J. Boisbouvier (IBS/NMR), period 2019-2024 - Malaria Vaccine Inititative (Collaboration UGA, Radboud Medical Center and PATH/MVI) : Malaria Transmission Blocking, contact : P. Poignard (IBS/HIP&HPV), period 2019-2020 - ANR grants obtained in 2019 :
|
Grants obtained in 2018The Grenoble Alliance for Integrated Structural & Cell Biology (GRAL) was selected for funding as a Laboratoire d’excellence (Labex) through the “Investissements d’avenir” programme of the French government in 2011. GRAL’s funding has been extended until 2028 (period 2018-2028). Contacts : Winfried Weissenhorn et François Parcy. - Subvention Région Auvergne-Rhône-Alpes, Pack Ambition Recherche 2018 - projet ACMAB - contact : P. Poignard (IBS/HIV&HPV), period 2018-2023 - Melinda Gates, projet ’Optimization of the LN02 Anti HIV Broadly Neutralizing Antibody’, contact : W. Weissenhonr (IBS/EBEV), period 2018-2020 - FINOVI Projet "Exploring the link between the human microbiome and colorectal cancer", contact A. Dessen (IBS/PATBAC), period 2018-2020 - Fondation DORMEUR, contact : P. Poignard (IBS/HIV&HPV), period 2018 - Fondation ARSEP, project APRIL (Un inhibiteur de plusieurs mécanismes de réparation de myéline ?), contact : H. Lortat-Jacob (IBS/ SAGAG), period 2018 - IDEX UGA - Projet DisRegulate "Intrinsically disordered regulators of endocytosis - Integrating single molecule fluorescence and nuclear magnetic resonance spectroscopies"- contact : Sigrid Milles (IBS/FDP), period 2018-2020 - 2018 CEA Grants :
- ANR grants obtained in 2018 :
|
Grants obtained in 2017- FINOVI projet "Resistance to Reactive Chlorine Species : new enzyme system used by intracellular pathogens as brucella ", contact : F. Fieschi IBS/M&P, period 2017-2019 - FINOVI Projet « Analysis of HIV broadly neutralizing antibody lineages ta inform vaccine design », IBS/VRM, équipe Poignard, period 2017-2019 - FINOVI, bourse de these, équipe Poignard (IBS/VRM), period 2017-2020 - H2020-INFRADEV INSTRUCT ULTRA (Releasing the full potential of Instruct to expand and consolidate infrastructure services for integrated structural life science research), contact : J. Boisbouvier (IBS/NMR), period 2017-2020 - Subvention Région - dispositif PACK AMBITION RECHERCHE 2017, Projet Xo4_2.0. (Cristallophore, nouvelle révolution en biologie structurale), contact E. Girard (IBS/ELMA), period 2017-2022 - Equipe FRM, projet "Interférence avec des interactions protéine-protéine au sein des machines réplicatives virales comme nouvelle approche thérapeutique", contact : M. Jamin (VRM), period 2017-2020 - IDEX-Initiatives de Recherche Stratégiques, projet HantaReplication (Structural characterization of highly pathogenic hantavirus replication machineries), contact H. Malet (IBS/MEM), period 2017-2018 - IDEX-Initiatives de Recherche Stratégiques, projet SPOinHD, contact C. Morlot (IBS/PG), period 2017-2018 - IDEX-Initiatives de Recherche Stratégiques, projet NER-Specificity (Réparation par excision de nucléotides - Nouvelles approches pour l’exploration de sa tes large spécificité de substrat), contact J. Timmins (IBS/VIC), period 2017-2020 - SATT projet Zetaquantor, contact E.Drouet (IBS/VRM), period 2017-2019 - SATT projet Deep Blue, contact B. Franzetti (IBS/ELMA), period 2017-2019 - ANR grants obtained in 2017 :
|